By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562



Company News
Ultragenyx (RARE) To Present At Upcoming Investor Conferences 11/11/2015 10:05:01 AM
Ultragenyx (RARE) Announces Update To UX007 Development Program In Glucose Transporter Type-1 Deficiency Syndrome 11/6/2015 11:42:55 AM
Arcturus Therapeutics Stands to Collect Up to $1.66 Billion from Rare Disease Pact with Ultragenyx (RARE) 10/29/2015 6:30:20 AM
Ultragenyx (RARE) Announces Positive Interim Data From Phase 2 Study Of UX007 In Long-Chain Fatty Acid Oxidation Disorder Patients 10/13/2015 12:14:40 PM
Ultragenyx (RARE) Announces Aceneuramic Acid Prolonged Release Marketing Authorization Application Filed And Accepted For Review By European Medicines Agency 10/2/2015 7:34:56 AM
Ultragenyx (RARE) To Present At The Baird Health Care Conference 9/2/2015 7:37:18 AM
Ultragenyx (RARE) Announces Presentation of Data From Long-Chain Fatty Acid Oxidation Disorder Patients With Cardiomyopathy Treated With Triheptanoin 9/1/2015 8:36:15 AM
Ultragenyx (RARE) Reports Second Quarter 2015 Financial Results And Corporate Update 8/14/2015 10:20:16 AM
Ultragenyx (RARE) To Host Conference Call For Second Quarter 2015 Financial Results And Corporate Update 8/6/2015 10:36:07 AM
Ultragenyx (RARE) Announces Initiation Of Phase II Study Of Recombinant Human Beta-Glucuronidase In Patients Under Five Years Old With Mucopolysaccharidosis 7 8/5/2015 7:20:39 AM